Investment enables Ten Bio to establish new skin testing technology in USA

A near-£1 million investment will help University of Dundee spinout company Ten Bio Ltd to commercialise the human skin culture system it developed to provide a viable alternative for many experiments currently performed on animals. Led by TRICAPITAL LTD and with matched funding from Scottish Enterprise, the investment of £911,000 will enable the company to progress its mission to transform the testing of new pharmaceutical and cosmetic products. Initial launch of the company’s brand will be in the US, where…

Read More

TenSkin used to show effects of filtered far-UVC radiation in skin

Ten Bio’s innovative human skin model, TenSkinTM, features in a recent publication assessing the carcinogenic risk through direct DNA damage of filtered far-UVC exposure. This work forms part of a concerted effort to evaluate the potential for full‐room inactivation of airborne SARS‐CoV‐2, the virus responsible for the COVID‐19 pandemic, using novel light sources, with an end goal of achieving rapid decontamination of occupied public spaces. This letter is published in the British Journal of Dermatology and is now available online…

Read More